Enanta Pharmaceuticals ENTA
NASDAQ ENTA
$12.84 -0.34 (-2.58%)
At close: Oct 1, 2026 · 4:00 PM EDT

Enanta Pharmaceuticals (ENTA) Preferred Stock Liabilities (2012 - 2026)

Updated

Enanta Pharmaceuticals (ENTA) reported Preferred Stock Liabilities of $1.31 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 2.9% from $1.35 million a year earlier and unchanged from the prior quarter.

Analysis

Enanta Pharmaceuticals (ENTA) Preferred Stock Liabilities (2012 - 2026) Analysis & Trends

Dating back to fiscal Q4 2012, Enanta Pharmaceuticals' Preferred Stock Liabilities record includes 49 quarters.

  • Preferred Stock Liabilities has a five-year compound annual growth rate of -2.4% (FY2020 to FY2025).
  • By fiscal year, Preferred Stock Liabilities came in at $1.35 million in FY2024 (-5.1%), $1.42 million in FY2023 (unchanged), $1.42 million in FY2022 (-5.5%) and $1.51 million in FY2021 (+1.8%).
  • Five-year quarterly Preferred Stock Liabilities spans a low of $1.31 million in fiscal Q4 2025 and a high of $1.51 million in fiscal Q3 2022.
  • Year over year, Preferred Stock Liabilities has now declined in each of the last eight quarters, with an average decline of 4.0% over the last eight quarters.
  • The high point for year-over-year Preferred Stock Liabilities in five years was fiscal Q3 2022 (growth of 1.8%); the low point was fiscal Q4 2022 (a decline of 5.5%).
  • Per Business Quant data, the three fiscal quarters before Q3 2026 came in at $1.31 million (Q2 2026), $1.31 million (Q1 2026) and $1.31 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Enanta Pharmaceuticals 383.80 Mn -344.19 Mn - 1.31 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.31 Mn
Mar 31, 2026 1.31 Mn
Dec 31, 2025 1.31 Mn
Sep 30, 2025 1.31 Mn
Jun 30, 2025 1.35 Mn
Mar 31, 2025 1.35 Mn
Dec 31, 2024 1.35 Mn
Sep 30, 2024 1.35 Mn
Jun 30, 2024 1.42 Mn
Mar 31, 2024 1.42 Mn
Dec 31, 2023 1.42 Mn
Sep 30, 2023 1.42 Mn
Jun 30, 2023 1.42 Mn
Mar 31, 2023 1.42 Mn
Dec 31, 2022 1.42 Mn
Sep 30, 2022 1.42 Mn
Jun 30, 2022 1.51 Mn
Mar 31, 2022 1.51 Mn
Dec 31, 2021 1.51 Mn
Sep 30, 2021 1.51 Mn
API Access

Enanta Pharmaceuticals Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=ENTA&period=max&api_key=YOUR_API_KEY